Intravenous Immunoglobulin Market at a CAGR of 6.30 % to hit USD 10,485.86 Million by 2023
There are abundant factors that is propelling the growth of the intravenous immunoglobulin market. These factors as per the MRFR (Market Research Future) report include rising occurrence of immunodeficiency diseases, growing geriatric population, increasing use of IVIG for various disease treatments, increasing utilization of off-label indications, growing number of hemophilic patients, enhanced purification techniques, improved technologies related to immunoglobulin production, and surge in occurrence of diseases namely hypogammaglobulinemia, chronic inflammatory demyelinating polyneuropathy and others. On the contrary, danger of side effects, strict regulations laid down by the government towards the utilization of intravenous immunoglobulin products and high treatment costs is likely to impede the growth of the intravenous immunoglobulin market over the predicted years. Most patients cannot afford this treatment owing to its soaring cost. Some of the side effects of undergoing the intravenous immunoglobulin treatment include abdominal pains, cough, high blood pressure, itching, fast heart rate, vomiting, nausea, fever, dizziness, migraine and headache.
Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/3137
Leading players profiled in the intravenous immunoglobulin market include Shire (Republic of Ireland), Octapharma (Switzerland), Kedrion S.p.A (US), Grifols Inc. (Spain), CSL Behring (US), China Biologic Products, Inc. (China), Biotest AG. (Germany), BDI Pharma (US), Baxter (US), ABEONA THERAPEUTICS (US), and others.
April 2019- FDA has approved ASCENIV, a new intravenous immune globulin for treating Primary Humoral Immunodeficiency Diseases (PI or PIDD) in adolescents and adults aged 12 to 17 years.
MRFR report offers a broad segmental analysis of the intravenous immunoglobulin market on the basis of type and application.
Based on type, the intravenous immunoglobulin market is segmented into IgA, IgD, IgE and IgG. IgA is further segmented into IgA1 and IgA2.
Based on application, the intravenous immunoglobulin market is segmented into CIPD (Monophasic, Recurrent, Progressive), Multifocal Motor Neuropathy, Hypogammaglobulinemia (AGM1, AGM2, AGM3, AGM4, AGM5 and AGM6), Immunodeficiency diseases (severe combined immunodeficiency, common variable immunodeficiency, x-linked agammaglobulinemia), Primary Humoral Immunodeficiency (unknown (idiopathic), complement deficiencies, defective phagocytes, combination B cell and T cell deficiencies, T cell deficiencies and B cell deficiencies (antibody)), Myasthenia Gravis (transient neonatal myasthenia gravis, congenital myasthenia gravis, ocular myasthenia gravis, and generalized myasthenia, Guillain-Barre syndrome (acute motor-sensory axonal neuropathy, acute motor axonal neuropathy, miller fisher syndrome, and acute inflammatory demyelinating polyradiculoneuropathy), Kawasaki disease and ITP (chronic and acute). Of these, hypogammaglobulinemia is expected to have the highest share in the market and also maintain its dominance over the predicted years.
By region, the intravenous immunoglobulin market covers growth opportunities and latest trends across Americas, Europe, Asia Pacific and Middle East and Africa. Of these, North America will govern the market over the predicted years owing to growing awareness of products used for treating immunodeficiency diseases, growing inclination of clinicians for such therapies as well as growing expenditure on healthcare. Besides, rising geriatric population susceptible to chronic diseases and changing lifestyle and growing occurrence of PID are also contributing to the growth of the market in this region. In Europe, the intravenous immunoglobulin market will have the second major share. The intravenous immunoglobulin market in the APAC region is predicted to have a lucrative growth over the predicted years owing to potential opportunities to adopt therapies that are immunoglobulin based to treat primary immune deficiencies, increasing awareness about intravenous immunoglobulin and increasing geriatric population. On the other hand, the intravenous immunoglobulin market in the Middle East and Africa will have a steady growth over the predicted years owing to less awareness regarding such treatment and therapies.
Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/intravenous-immunoglobulin-market-3137
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York, New York 10013,
United States of America
+1 646 845 9312
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Intravenous Immunoglobulin Market at a CAGR of 6.30 % to hit USD 10,485.86 Million by 2023 here
News-ID: 2540077 • Views: 308
More Releases from Market Research Future (MRFR)
Sports Medicine Market expected to reach US$9,655.6 million By 2023 at CAGR of 8 …
The global sports medicine market will grow at a CAGR of 8.9% during the forecast period 2017 to 2023. The market for sports medicine is set to reach US$9,655.6 million by 2023. As per sports medicine analysts, the global market is anticipated to witness growth owing to the factors such as on-going technological development as well as the expansion of medical associations. However, sports medicine will face challenges and restraints
Tumor Ablation Market Size, Share, Trends, Demand, Growth, Regional Analysis And …
Market Highlights: Tumor ablation is a technique of removal of cancer tissue or cells of kidney, liver, bone, and soft tissue with invasive procedure. It is considered as excellent and convenient treatment option over other conventional surgical techniques. Factors that are propelling the growth of the tumor ablation market are surge in geriatric population, increase in prevalence of different types of cancer, rise in adoption of minimally invasive surgical procedures, increasing
Compound Feed Market, Key Players Analysis, Business Growth, Regional Trends, De …
Market Overview Market Research Future (MRFR) assessed the global compound feed market 2020 for the assessment period till 2023. The global compound feed market value can expand at 4.02% CAGR through the review period. By 2023, the compound feed market can value at USD 539.99 Bn, asserts MRFR findings. Covid-19 analysis on compound feed market is released with the report. Information offered under Covid-19 compound feed market analysis by proficient researchers
Biological Seed Treatment Market, Industry Size, Share Leaders, Current Status b …
Market Highlights Demand for biologically treated seeds is fuelled by growing understanding of seed care, environmental issues and increasing demand for organic food production, and an overall emphasis on increasing the quality of agricultural produce. The industry is impacted by the introduction of sustainable farming practises, along with major market players making heavy investments in the research and production of these goods. Over the projected era, rising demand for chemical-free crops
More Releases for USD
$100,000,000 USD job contract for travel - $3,000,000 USD referral commission.
Khoja Consultants invites companies, teams or venture capitalists for a $100,000,000 USD contract for travel. The selected company will be providing all accommodations and expenses for a 6-month long business trip around the world. Khoja Consultants expects five-star treatment including close security with private planes, hotels, secured vehicles and helicopters if necessary. More details on the job contract and application are provided at - www.KhojaConsultants.com. There is a $3,000,000
Polyurethane Dispersions Market worth USD 2.04 Billion USD by 2020
The report " Polyurethane Dispersions Market by Type (Water-Based Polyurethane Dispersions and Solvent-Based Polyurethane Dispersions), by Application (Coatings, Adhesives & Sealants, Synthetic Leather Production, Fiber Glass Sizing, and Others) - Trends & Forecasts to 2020", The global polyurethane dispersions market is projected to reach USD 2.04 Billion by 2020 at a CAGR of 6.8% between 2015 and 2020. This growth is fueled by the high potential from the textile and
Retail Analytics Market worth USD 5.1 Billion USD by 2020
According to a new market research report "Retail Analytics Market by Business Function (Marketing and Customer Analytics, Merchandizing and In-Store Analytics, Supply Chain Analytics, Strategy and Planning), by Type, by Solutions and by Services - Global Forecast and Analysis to 2020", defines and segments the global retail analytics market on the basis of business function, solutions, services, deployment types, and regions along with providing an in-depth analysis and market size
Metabolomics Market USD 1.24 Billion by 2020
The global metabolomics market is estimated to reach USD 1.24 Billion in 2020, growing at a CAGR of 15.6% from 2016 to 2020, according to a market research report Metabolomics Market 2013-2020, published by iHealthcareAnalyst, Inc. Visit the Metabolomics Market 2013-2020 report at https://www.ihealthcareanalyst.com/report/metabolomics-market/ Metabolomics is the scientific study of chemical processes involving metabolites, whereas metabolome represents the collection of all metabolites in a biological cell, tissue, organ or organism, which
Radiopharmaceuticals Market USD 350 Million by 2020
Radiopharmaceuticals Market 2013-2020 report estimates the global radiopharmaceuticals market to reach nearly USD 350 Million in 2020, at a CAGR of 4.9% from 2016 to 2020 - iHealthcareAnalyst, Inc. Visit the Radiopharmaceuticals Market 2013-2020 report https://www.ihealthcareanalyst.com/report/radiopharmaceuticals-market/ Medicinal radiocompounds or radiopharmaceuticals are a group of pharmaceutical drugs which have radioactivity and they can be used as diagnostic and therapeutic agents. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers
Orthobiologics Market USD 5.8 Billion by 2020
Orthobiologics Market 2013-2020 report estimates the global orthobiologics market to reach nearly USD 5.8 Billion in 2020, at a CAGR of 6.2% from 2016 to 2020 - iHealthcareAnalyst, Inc. Visit the Orthobiologics Market 2013-2020 report https://www.ihealthcareanalyst.com/report/orthobiologics-market/ The global orthobiologics market report provides market size (Revenue USD Million 2013 to 2020), market share and forecasts growth trends (CAGR%, 2016 to 2020). The global orthobiologics market segmentation is based on product types (allograft, bone